NC

Neil Roy Curtis

Merck: 31 patents #249 of 9,382Top 3%
MD Merk Sharp & Dohme: 1 patents #1 of 28Top 4%
Overall (All Time): #108,869 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 25 most recent of 33 patents

Patent #TitleCo-InventorsDate
7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists Mark Stuart Chambers, Emanuela Gancia, Myra Gilligan, Alexander Humphries, Tamara Ladduwahetty +2 more 2009-09-22
7276607 5-HT7 receptor antagonists Peter Hunt, Janusz Jozef Kulagowski 2007-10-02
7094777 5-HT2A receptor ligands Mark Stuart Chambers, Angus Murray MacLeod, Robert Maxey, Helen Jane Szekeres 2006-08-22
6727249 Azabicyclic ether derivatives and their use as therapeutic agents Ian Thomas Huscroft, Janusz Jozef Kulagowski, Piotr Raubo 2004-04-27
6613765 Use of NK-1 receptor antagonists for treating major depressive disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 2003-09-02
6613766 Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa &agr;5 receptors Janusz Jozef Kulagowski, Francine Sternfeld 2003-09-02
6395766 Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition Howard Barff Broughton, Helen Jane Bryant, Mark Stuart Chambers 2002-05-28
6319944 Aryl amidines, compositions containing such compounds and methods of use Christopher F. Claiborne, Nigel J. Liverton, Brian Libby, Janusz Kulagowski 2001-11-20
6271230 Use of NK-1 receptor antagonists for treating cognitive disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Janusz Jozef Kulagowski +5 more 2001-08-07
6172077 Spiro-azacyclic derivatives and their use as therapeutic agents Jason Matthew Elliott, Gregory John Hollingworth, Philip Stephen Jackson, Janusz Jozef Kulagowski, Eileen Mary Seward +2 more 2001-01-09
6114315 Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 2000-09-05
6100256 Use of NK-1 receptors antagonists for treating schizophrenic disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 2000-08-08
6096729 Use of NK-1 receptor antagonists for treating amnestic disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 2000-08-01
6087348 Use of NK-1 receptor antagonists for treating stress disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 2000-07-11
6071928 Spiro-piperidine derivatives and their use as therapeutic agents Ian Thomas Huscroft, Janusz Jozef Kulagowski, Christopher John Swain 2000-06-06
6071927 Spiro-piperidine derivatives and their use as therapeutic agents Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +4 more 2000-06-06
5977104 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 1999-11-02
5952315 Use of NK-1 receptor antagonists for treating bipolar disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 1999-09-14
5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 1999-07-27
5925627 Use of NK-1 receptor antagonists for treating movement disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 1999-07-20
5919781 Use of NK-1 receptor antogonists for treating substance use disorders Raymond Baker, Jason Matthew Elliott, Timothy Harrison, Gregory John Hollingworth, Philip Stephen Jackson +5 more 1999-07-06
5861407 Tetrahydropyridine derivatives as dopamine receptor subtype ligands Janusz Jozef Kulagowski, Paul D. Leeson, Ian M. Mawer, Mark Peter Ridgill 1999-01-19
5849765 Tetrahydropyridine derivatives as dopamine receptor subtype ligands Janusz Jozef Kulagowski, Paul D. Leeson, Kevin W. Moore, Andrew Pate Owens, Martin Teall 1998-12-15
5830901 Tetrahydropyridinylmethyl derivatives of pyrrolo2,3-B!pyridine Janusz Jozef Kulagowski, Paul D. Leeson, Mark Peter Ridgill 1998-11-03
5712285 Pyrrolo-pyridine derivatives Janusz Jozef Kulagowski, Paul D. Leeson, Mark Peter Ridgill 1998-01-27